Valuation (38%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -4.07 | N/A |
| PEG Ratio (TTM) | -0.15 | N/A |
| P/S Ratio (TTM) | 0.34 | N/A |
| P/B Ratio (TTM) | 1.03 | N/A |
| P/FCF Ratio (TTM) | N/A | N/A |
| Price to 5YR AVG Earnings Ratio | 2.47 | N/A |
| Price to 5YR AVG FCF Ratio | -0.50 | N/A |
Profitability (3%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -8.87% | N/A |
| ROE (TTM) | -24.15% | N/A |
| Net Profit Margin (TTM) | -8.51% | N/A |
| ROIC 5YR AVG | 1.48% | N/A |
Growth (58%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -4.65% | 47.72% | -81.01% |
| Revenue | 13.07% | 36.59% | 15.80% |
| Net Income | -3.95% | 59.03% | -78.88% |
| Cash Flow | N/A | 776.40% | 418.11% |
Health (28%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.33 | N/A |
| Quick Ratio (TTM) | 0.94 | N/A |
| D/E Ratio (TTM) | 0.46 | N/A |
| Interest Coverage (TTM) | -64.87 | N/A |
| Piotroski F-Score | 4 | N/A |
| Altman Z-Score | 0.53 | N/A |
| LTL to 5YR AVG FCF | 0.00 | N/A |
| Shares Outstanding Growth 5YR AVG | 26.32% | N/A |